Literature DB >> 23945161

Seroepidemiologies of human metapneumovirus and respiratory syncytial virus in young children, determined with a new recombinant fusion protein enzyme-linked immunosorbent assay.

Sarah R Dunn1, Alex B Ryder, Sharon J Tollefson, Meng Xu, Benjamin R Saville, John V Williams.   

Abstract

We compared antibodies against human metapneumovirus (HMPV) and respiratory syncytial virus (RSV) in children. The antibody nadirs for both viruses were at 3 to 5 months, and the majority of children were seropositive for both by 2 years. There was no significant difference in the kinetics of maternal antibody decline or seroconversion relative to the two viruses.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23945161      PMCID： PMC3807191          DOI： 10.1128/CVI.00750-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  34 in total

1.  Analysis of the genomic sequence of a human metapneumovirus.

Authors:  Bernadette G van den Hoogen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Virology       Date:  2002-03-30       Impact factor: 3.616

2.  Seroepidemiological study of human metapneumovirus in New Delhi, India.

Authors:  S Banerjee; W M Sullender; R K Ahuja; S Broor
Journal:  Indian J Med Microbiol       Date:  2011 Oct-Dec       Impact factor: 0.985

3.  Human metapneumovirus infections in young and elderly adults.

Authors:  Ann R Falsey; Dean Erdman; Larry J Anderson; Edward E Walsh
Journal:  J Infect Dis       Date:  2003-02-24       Impact factor: 5.226

4.  High seroprevalence of human metapneumovirus among young children in Israel.

Authors:  Dana G Wolf; Zichria Zakay-Rones; Ayman Fadeela; David Greenberg; Ron Dagan
Journal:  J Infect Dis       Date:  2003-12-05       Impact factor: 5.226

5.  Seroprevalence of human metapneumovirus in Japan.

Authors:  Takashi Ebihara; Rika Endo; Hideaki Kikuta; Nobuhisa Ishiguro; Mikio Yoshioka; Xiaoming Ma; Kunihiko Kobayashi
Journal:  J Med Virol       Date:  2003-06       Impact factor: 2.327

6.  Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children.

Authors:  John V Williams; Paul A Harris; Sharon J Tollefson; Lisa L Halburnt-Rush; Joyce M Pingsterhaus; Kathryn M Edwards; Peter F Wright; James E Crowe
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

7.  Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients.

Authors:  Bernadette G van den Hoogen; Gerard J J van Doornum; John C Fockens; Jan J Cornelissen; Walter E P Beyer; Ronald de Groot; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  J Infect Dis       Date:  2003-10-27       Impact factor: 5.226

8.  RSV and HMPV seroprevalence in Tuscany (Italy) and North-Rhine Westfalia (Germany) in the winter season 2009/2010.

Authors:  Maria G Cusi; Chiara Terrosi; Michael Kleines; Oliver Schildgen
Journal:  Influenza Other Respir Viruses       Date:  2011-04-18       Impact factor: 4.380

9.  Human metapneumovirus infections in hospitalized children.

Authors:  Guy Boivin; Gaston De Serres; Stéphanie Côté; Rodica Gilca; Yacine Abed; Louis Rochette; Michel G Bergeron; Pierre Déry
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

10.  Children with respiratory disease associated with metapneumovirus in Hong Kong.

Authors:  J S Malik Peiris; Wing-Hong Tang; Kwok-Hung Chan; Pek-Lan Khong; Yi Guan; Yu-Lung Lau; Susan S Chiu
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883
View more
  7 in total

1.  Novel HLA-A2-restricted human metapneumovirus epitopes reduce viral titers in mice and are recognized by human T cells.

Authors:  Andrew K Hastings; Pavlo Gilchuk; Sebastian Joyce; John V Williams
Journal:  Vaccine       Date:  2016-04-19       Impact factor: 3.641

2.  Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.

Authors:  Andrew K Hastings; John J Erickson; Jennifer E Schuster; Kelli L Boyd; Sharon J Tollefson; Monika Johnson; Pavlo Gilchuk; Sebastian Joyce; John V Williams
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

3.  Human metapneumovirus in the preterm neonate: current perspectives.

Authors:  Nathalie L Maitre; John V Williams
Journal:  Res Rep Neonatol       Date:  2016-07-28

4.  Comparing Human Metapneumovirus and Respiratory Syncytial Virus: Viral Co-Detections, Genotypes and Risk Factors for Severe Disease.

Authors:  Nina Moe; Sidsel Krokstad; Inger Heimdal Stenseng; Andreas Christensen; Lars Høsøien Skanke; Kari Ravndal Risnes; Svein Arne Nordbø; Henrik Døllner
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

5.  STAT2 Limits Host Species Specificity of Human Metapneumovirus.

Authors:  Meredith C Rogers; Margot Miranda-Katz; Yu Zhang; Tim D Oury; Melissa B Uccellini; Adolfo García-Sastre; John V Williams
Journal:  Viruses       Date:  2020-07-04       Impact factor: 5.048

6.  Novel HLA-B7-restricted human metapneumovirus epitopes enhance viral clearance in mice and are recognized by human CD8+ T cells.

Authors:  Margot Miranda-Katz; John J Erickson; Jie Lan; Alwyn Ecker; Yu Zhang; Sebastian Joyce; John V Williams
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.996

Review 7.  Human metapneumovirus - what we know now.

Authors:  Nazly Shafagati; John Williams
Journal:  F1000Res       Date:  2018-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.